Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug 9:6:Doc04.
doi: 10.3205/id000039. eCollection 2018.

Medical treatment for urogenital tuberculosis (UGTB)

Affiliations
Review

Medical treatment for urogenital tuberculosis (UGTB)

Christian Wejse. GMS Infect Dis. .

Abstract

Urogenital tuberculosis (UGTB) should in general be treated as pulmonary TB with a four-drug regimen of Isoniazid, Rifampicin, Ethambutol and Pyrazinamide for a total of 6 months, Ethambutol and Pyrazinamide only the first two months. Some patients may need longer treatment (cavitary disease, kidney abscess/malfunction, HIV co-infection). Treatment of multi-drug resistant tuberculosis (MDR-TB) requires use of long-term intravenous treatment with aminoglycosides and other drugs with considerable toxicity for 18-24 months. Complications such as urinary tract obstruction may occur and should be treated with corticosteroids or surgery.

PubMed Disclaimer

Figures

Table 1
Table 1. Treatment regimen for UGTB
Table 2
Table 2. Dose-reduction according to weight (adults <50 kg)
Table 3
Table 3. Drugs used for treatment of multi-drug resistant tuberculosis (MDR-TB)
Table 4
Table 4. Reduced kidney function (creatinin clearance
<30 ml/min); dose-reduction, adults

References

    1. Gow JG, Barbosa S. Genitourinary tuberculosis. A study of 1117 cases over a period of 34 years. Br J Urol. 1984 Oct;56(5):449–455. - PubMed
    1. Cek M, Lenk S, Naber KG, Bishop MC, Johansen TE, Botto H, Grabe M, Lobel B, Redorta JP, Tenke P Members of the Urinary Tract Infection (UTI) Working Group of the European Association of Urology (EAU) Guidelines Office. EAU guidelines for the management of genitourinary tuberculosis. Eur Urol. 2005 Sep;48(3):353–362. doi: 10.1016/j.eururo.2005.03.008. - DOI - PubMed
    1. Kulchavenya E, Naber K, Bjerklund Johansen TE. Urogenital Tuberculosis: Classification, Diagnosis, and Treatment. Eur Urol Suppl. 2016 Jul;15(4):112–21. doi: 10.1016/j.eursup.2016.04.001. - DOI
    1. Chandra S, Chandra H, Chauhan N, Gaur DS, Gupta H, Pathak VP, Burathoki SK. Male genitourinary tuberculosis – 13 years experience at a tertiary care center in India. Southeast Asian J Trop Med Public Health. 2012 Mar;43(2):364–369. - PubMed
    1. World Health Organization. Global tuberculosis report 2017. Geneva: World Health Organization; 2017. Available from: http://www.who.int/tb/publications/global_report/en/